Who Exports Heparin from India — 391 Suppliers Behind a $352.8M Market
India's heparin export market is supplied by 391 active exporters who collectively shipped $352.8M across 4,586 shipments. GLAND PHARMA LIMITED leads with a 35.6% market share, followed by GLAND PHARMA LTD and CAPLIN POINT LABORATORIES LIMITED. The top 5 suppliers together control 82.6% of total export value, reflecting a concentrated market structure.
Top Heparin Exporters from India — Ranked by Export Value
GLAND PHARMA LIMITED is the leading heparin exporter from India, holding a 35.6% share of the $352.8M market across 4,586 shipments from 391 exporters. The top 5 suppliers — GLAND PHARMA LIMITED, GLAND PHARMA LTD, CAPLIN POINT LABORATORIES LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — collectively control 82.6% of total export value, indicating a highly concentrated market. Individual shares are: GLAND PHARMA LIMITED (35.6%), GLAND PHARMA LTD (27.8%), CAPLIN POINT LABORATORIES LIMITED (8.9%), PFIZER HEALTHCARE INDIA PRIVATE LIMITED (7.3%), MYLAN LABORATORIES LIMITED (3.0%).
Top Heparin Exporters from India
Ranked by export value · 391 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LIMITED LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN INJECTION BP 25000 IU/5ML,5ML VI | $125.7M | 32 | 35.6% |
| 2 | GLAND PHARMA LTD LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN INJECTION BP 25000 IU/5ML,5ML VI | $98.0M | 32 | 27.8% |
| 3 | CAPLIN POINT LABORATORIES LIMITED HEPARIN INJECTIONHEPARIN SODIUM INJECTION USP 5000IU/ML -5MLHEPARIN SODIUM INJECTION USP 5000IU/ML -5MLVIAL | $31.5M | 4 | 8.9% |
| 4 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $25.6M | 1 | 7.3% |
| 5 | MYLAN LABORATORIES LIMITED HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $10.7M | 1 | 3.0% |
| 6 | SAKAR HEALTHCARE LIMITED HEPARIN INJECTION BP SAKARIHEPARIN INJECTION BP SAKARIN 25000HEPARIN INJECTION BP SAKARIN 5000 | $8.9M | 3 | 2.5% |
| 7 | TROIKAA PHARMACEUTICALS LIMITED HEPARIN INJECTION BP 25000 IU/5ML,5ML VIHEPARIN INJECTION BP,25000IU/5ML,5ML VIAHEPARIN INJECTION BP SAKARI | $7.3M | 8 | 2.1% |
| 8 | JODAS EXPOIM PRIVATE LIMITED HEPARIN SODIUM SOLUTION FOR INTRAVENOUSHEPARIN-RUS 25000 IUHEPARIN - RUS 25000 IU | $6.6M | 2 | 1.9% |
| 9 | ACULIFE HEALTHCARE PRIVATE LIMITED HEPARIN INJECTION BP 25000IU/5ML, 5ML VIALNOSHEPARIN INJECTION BP 25000 IU/5ML5ML VIHEPARIN INJECTION BP, 25000IU/5ML, 5ML VIAL | $5.2M | 13 | 1.5% |
| 10 | EMCURE PHARMACEUTICALS LIMITED LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN INJECTION BP SAKARIHEPARIN INJECTION BP SAKARIN 25000 | $3.9M | 15 | 1.1% |
| 11 | EUGIA PHARMA SPECIALITIES LIMITED | $2.8M | 2 | 0.8% |
| 12 | TC WORLD | $2.1M | 1 | 0.6% |
| 13 | BIOLOGICAL E. LIMITED HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $1.9M | 2 | 0.5% |
| 14 | SCOTT EDIL PHARMACIA LIMITED | $1.7M | 10 | 0.5% |
| 15 | U SQUARE LIFESCIENCE PRIVATE LIMITED LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN INJECTION BP 25000 IU/5ML,5ML VI | $1.2M | 1 | 0.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Heparin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| GLAND PHARMA LIMITED | Approved | Yes | Yes | Multiple | Received US FDA approval for Phytonadione Injectable Emulsion USP on December 11 |
| MYLAN LABORATORIES LIMITED | Approved | Yes | Yes | Multiple | Listed as a foreign MNC in the PLI scheme as of May 3, 2023. |
| EMCURE PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Multiple | Listed as a domestic applicant in the PLI scheme as of May 3, 2023. |
| BIOLOGICAL E. LIMITED | Approved | Yes | Yes | Multiple | Listed as a domestic applicant in the PLI scheme as of May 3, 2023. |
| SCOTT EDIL PHARMACIA LIMITED | Not Listed | Yes | Yes | Not Listed | WHO-GMP certified manufacturing units listed in CDSCO document. |
| JODAS EXPOIM PRIVATE LIMITED | Not Listed | Yes | Yes | Not Listed | Specializes in generic injectables; WHO-GMP certified. (ensun.io) |
| TROIKAA PHARMACEUTICALS LIMITED | Not Listed | Yes | Yes | Not Listed | WHO-GMP certified; specializes in innovative drug delivery systems. |
| CAPLIN POINT LABORATORIES LIMITED | Approved | Yes | Yes | Multiple | WHO-GMP certified; focuses on emerging markets. |
| SAKAR HEALTHCARE LIMITED | Not Listed | Yes | Yes | Not Listed | WHO-GMP certified; specializes in injectables and oral formulations. |
| ACULIFE HEALTHCARE PRIVATE LIMITED | Not Listed | Yes | Yes | Not Listed | WHO-GMP certified; focuses on large volume parenterals. |
TransData Nexus reviewed the regulatory standing of 10 leading Heparin exporters from India. 5 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Heparin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) production. The city hosts numerous manufacturers specializing in APIs, including Heparin. Companies like Gland Pharma Limited, a leading exporter of Heparin with exports totaling $125.7 million (35.6% of total Heparin exports), are headquartered here. The region's robust infrastructure and skilled workforce make it a cornerstone for bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This area is home to companies such as Intas Pharmaceuticals and Zydus Lifesciences, which are involved in the production of finished dosage forms, including Heparin injections. The presence of these firms underscores the region's significance in the formulation segment of the pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Companies like Shamrock Group, based in Mumbai, are involved in the manufacturing and export of Heparin and its derivatives. The strategic location of this cluster facilitates efficient international distribution, contributing significantly to India's Heparin exports.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, largely due to favorable tax incentives. This area attracts numerous pharmaceutical companies, including those producing Heparin formulations. The fiscal benefits and supportive infrastructure have made it an attractive destination for pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers to ensure consistent quality and regulatory adherence.
- Leverage Export Hubs: Utilize suppliers located in export-centric regions like Mumbai-Thane-Raigad for streamlined international logistics.
- Monitor Regulatory Changes: Stay informed about regional tax incentives and regulatory changes that may impact supplier operations and cost structures.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance supply chain resilience and ensure a steady supply of Heparin to meet global demand.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Heparin exporters from India
Caplin Point Laboratories Limited — Caplin Point acquires 10 ANDAs, targets $473M US market
Caplin Point Laboratories, through its subsidiaries Caplin Steriles Limited and Caplin One Labs Limited, acquired 10 approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic manufacturer. This portfolio addresses a market valued at $473.2 million for the 12 months ending August 2025. - IMPACT: This acquisition is expected to enhance Caplin Point's product offerings, potentially increasing its Heparin export capacity.
Impact: This acquisition is expected to enhance Caplin Point's product offerings, potentially increasing its Heparin export capacity.
Common Questions — Heparin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which heparin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, GLAND PHARMA LIMITED leads with 763 recorded shipments worth $125.7M. GLAND PHARMA LTD (906 shipments) and CAPLIN POINT LABORATORIES LIMITED (74 shipments) are also established high-volume exporters.
Q How many heparin manufacturers are there in India?
India has 391 active heparin exporters with a combined export market of $352.8M across 4,586 shipments to 137 countries. The top 5 suppliers hold 82.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for heparin from India?
Average FOB unit price: $58.66 per unit, ranging from $0.00 to $24946.48. Average shipment value: $76.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 391 verified Indian exporters of Heparin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,586 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 137 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,586 Verified Shipments
391 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists